Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine, bortezomib, and rituximab in previously untreated low-grade non-Hodgkin lymphoma has completed, with …
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Spectroscopy With Surface Coils and Decoupling [Phase 1]
A Phase 1 clinical trial evaluating spectroscopy with surface coils and decoupling has completed, across multiple cancer indications. Sponso…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning [Phase 1]
This entry reports a Phase 1 clinical trial evaluating breathing-synchronized CT and PET scans to guide radiation therapy planning. The spon…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluated GM-CSF and rituximab after autologous stem cell transplant in patients with relapsed or refractory follicular non-…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma [Phase 3]
Phase 3 randomized trial comparing tacrolimus/sirolimus/methotrexate to tacrolimus/methotrexate or cyclosporine/mycophenolate mofetil for GV…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT [NA]
This completed clinical trial evaluates whether FDG PET imaging can predict residual disease. It also examines subsequent relapse in patient…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [NA]
ClinicalTrials.gov update indicates completion of a study assessing cytogenetic analysis of bone marrow before high-dose chemotherapy and au…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
A completed clinical trial update assessing structural brain imaging and cognitive function in adult stem cell transplant recipients treated…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-Tac labeled with Yttrium-90 (90Y-HAT) for Hodgkin lymphoma, Non-Hodgkin lymphoma, and lymphoid leuk…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Mozobil for Autologous Stem Cell Mobilization [Phase 2]
Phase 2 trial update for Mozobil (plerixafor) assessing autologous stem cell mobilization has completed in Non-Hodgkin's Lymphoma and Hodgki…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies [Phase 1]
Phase 1 safety study of carfilzomib (PR-171) in hematologic malignancies has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies [Phase 1]
This update reports the completion of a Phase 1 pediatric study evaluating panobinostat in children with refractory hematologic malignancies…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma [Phase 1]
A Phase 1 clinical trial of a vaccine therapy for patients with recurrent B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
This trial update summarizes results for patients with low-grade non-Hodgkin lymphoma who were previously treated with Tositumomab and/or io…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer [Phase 1]
Pfizer's Phase 1 study of the CDK4/6 inhibitor palbociclib in patients with advanced cancer, including Non-Hodgkin lymphoma, has completed a…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update reports Phase 2 results for radioimmunotherapy in patients with relapsed or refractory non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment [Phase 2]
Phase 2 study evaluating YM155 in combination with Rituximab in patients with previously treated Non-Hodgkin's Lymphoma; the trial status is…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
This clinical trial update reports the long-term effects of combining Iodine-131 labeled tositumomab with autologous bone marrow or stem cel…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial of Galiximab plus Rituximab versus Rituximab plus placebo in follicular non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit [Phase 2]
Phase 2 clinical trial evaluating hematopoietic stem cell transplantation using a CD34-selected mismatched related donor plus one umbilical …
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial of rituximab in young patients receiving chemotherapy for B-cell non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia h…